<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Pharmaceutical Industry Today: Pharmaceutical Companies News</title>
<link>http://pharmaceuticals.einnews.com/archive/pharma_companies</link><description>Constantly updated news and information about pharmaceutical industry.</description><item>
<title>Merck&apos;s Vioxx study &apos;a marketing ploy&apos;</title>
<link>http://pharmaceuticals.einnews.com/news.php?fid=172661723</link>
<pubDate>20 Aug 2008 07:38 GMT</pubDate>
<description>
TRENTON  A 1999 Merck study of its since-withdrawn painkiller Vioxx, touted to participating doctors and patients as meant to show whether Vioxx caused  ...
</description>
</item><item>
<title>Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma</title>
<link>http://pharmaceuticals.einnews.com/news.php?fid=172650563</link>
<pubDate>20 Aug 2008 06:28 GMT</pubDate>
<description>
Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma Elotuzumab Antibody Designed to Target Highly Expressed Cell Surface  ...
</description>
</item><item>
<title>Researchers: Merck Vioxx Study Was for Marketing - August 19, 2008</title>
<link>http://pharmaceuticals.einnews.com/news.php?fid=172642316</link>
<pubDate>20 Aug 2008 05:32 GMT</pubDate>
<description>
Researchers: Merck Vioxx Study Was for Marketing TRENTON, N.J. (AP) -- A 1999 Merck &amp; Co. study of its since-withdrawn painkiller Vioxx, touted to participating  ...
</description>
</item><item>
<title>Researchers: Merck Vioxx study was for marketing</title>
<link>http://pharmaceuticals.einnews.com/news.php?fid=172638292</link>
<pubDate>20 Aug 2008 05:15 GMT</pubDate>
<description>
TRENTON, N.J. - A 1999 Merck &amp; Co. study of its since-withdrawn painkiller Vioxx, touted to participating doctors and patients as meant to show whether  ...
</description>
</item><item>
<title>Merck Vioxx study was for marketing: researchers</title>
<link>http://pharmaceuticals.einnews.com/news.php?fid=172635185</link>
<pubDate>20 Aug 2008 04:11 GMT</pubDate>
<description>
 ...
</description>
</item><item>
<title>Merck Vioxx study was aimed at marketing: report</title>
<link>http://pharmaceuticals.einnews.com/news.php?fid=172631716</link>
<pubDate>20 Aug 2008 03:30 GMT</pubDate>
<description>
 ...
</description>
</item><item>
<title>Report: Study was marketing move That&apos;s latest in saga of Merck&apos;s Vioxx</title>
<link>http://pharmaceuticals.einnews.com/news.php?fid=172617755</link>
<pubDate>20 Aug 2008 01:00 GMT</pubDate>
<description>
Report: Study was marketing move That&apos;s latest in saga of Merck&apos;s Vioxx The Trenton Times (NJ) - Aug. 19, 2008 A 1999 Merck study  ...
</description>
</item><item>
<title>Genentech Launches Employee Retention Program</title>
<link>http://pharmaceuticals.einnews.com/news.php?fid=172614993</link>
<pubDate>20 Aug 2008 00:33 GMT</pubDate>
<description>
 ...
</description>
</item><item>
<title>Merck Vioxx Study Was For Marketing: Researchers Conclude</title>
<link>http://pharmaceuticals.einnews.com/news.php?fid=172610678</link>
<pubDate>20 Aug 2008 00:20 GMT</pubDate>
<description>
Merck Vioxx Study Was For Marketing: Researchers Conclude NEW YORK AUG 19, 2008 (Reuters) - The primary purpose of a 1999 clinical study that Merck &amp; Co  ...
</description>
</item><item>
<title>Merck Vaccine Market Takes Center Stage</title>
<link>http://pharmaceuticals.einnews.com/news.php?fid=172606591</link>
<pubDate>19 Aug 2008 23:58 GMT</pubDate>
<description>
 ...
</description>
</item><item>
<title>Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to Develop Novel &amp;hellip;</title>
<link>http://pharmaceuticals.einnews.com/news.php?fid=172595213</link>
<pubDate>19 Aug 2008 22:33 GMT</pubDate>
<description>
 ...
</description>
</item><item>
<title>Merck Vioxx Study Disguised Marketing as Science</title>
<link>http://pharmaceuticals.einnews.com/news.php?fid=172593699</link>
<pubDate>19 Aug 2008 22:30 GMT</pubDate>
<description>
A study that touted the benefits of Vioxx, a painkiller that killed thousands, wasn&apos;t science: it was marketing propaganda. &quot;The trial was designed by  ...
</description>
</item><item>
<title>Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma</title>
<link>http://pharmaceuticals.einnews.com/news.php?fid=172580617</link>
<pubDate>19 Aug 2008 20:52 GMT</pubDate>
<description>
 ...
</description>
</item><item>
<title>Genentech to Roche: We&apos;re worth more</title>
<link>http://pharmaceuticals.einnews.com/news.php?fid=172568666</link>
<pubDate>19 Aug 2008 20:07 GMT</pubDate>
<description>
SOUTH SAN FRANCISCO, Calif. - Genentech announced Aug. 13 it had rejected Roche&apos;s offer to purchase all outstanding Genentech stock shares. A special committee of  ...
</description>
</item><item>
<title>Merck &amp; Co Marketing Created Vioxx Study</title>
<link>http://pharmaceuticals.einnews.com/news.php?fid=172567212</link>
<pubDate>19 Aug 2008 20:00 GMT</pubDate>
<description>
Merck &amp; Co called the 1999 research study, Advantage. The drug maker said it was testing the side effects of the soon-to-be-launched painkiller,  ...
</description>
</item></channel>
</rss>
